8 results
Lower GI Bleeding - Scoping Summary
 • Hematochezia
 • History and Physical
 • LGI Bleeding and
Lower GI Bleeding ... Dual Antiplatelet Therapy ... • Risk Stratification ... in GI Bleeding ... diagnosis #management #algorithm
CHA2DS2VASc vs HAS-BLED scores for stroke risk and bleed risk on anticoagulation

C	Congestive Heart Failure	1

H	Hypertension	1

A2	Age >75	2

D	Diabetes Mellitus	1

S2	Stroke,
and bleed risk ... renal replacement therapy ... S Stroke 1 B Bleeding ... Anti-platelet agent ... CHADS2VASc #HASBLED #Comparison
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
anticoagulant therapy ... patients at high risk ... of bleeding. ... risk during follow-up ... also balance the risk
Mild-to-Moderate Ulcerative Colitis - Management Algorithm
Curcumin:
 • Natural phytochemical from turmeric
 • 2g/day divided in 2-3
placebo • Potential GI ... with long-term dosing ... given risk for ... consider decreased dosing ... combination PO/PR 5-ASA therapy
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Any adverse events ... complications from anesthesia ... event, follow ACC algorithm ... - what is the bleeding ... postoperative cardiac events
Endoscopy in Non-Variceal Upper GI Bleeding - Scoping Summary
Pre-Endoscopic Care:
 • Adequate resuscitation: Restrictive> Liberal strategy
Non-Variceal Upper GI ... Bleeding - Scoping ... sens. >12 inc. risk ... Assessment and Therapy ... diagnosis #management #algorithm
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... The goals of therapy ... progression and death, thereby ... an infection or bleeding ... #algorithm #hematology
Summary of Oncologic Emergencies

Neutropenic fever:
- Fever + ANC < 500 → start cefepime ± vancomycin (if
24-48 h and ANC rising ... mg/dL or > 25 % rise ... Simultaneous clotting and bleeding ... therapy - Symptoms ... differentiating agent